Recent developments in the medical and surgical treatment of melanoma

Area of Science:

• Oncology
• Dermatology
• Pharmacology

Background:

• Melanoma treatment has evolved significantly due to increased biological understanding.
• Surgery remains crucial for localized melanoma and advanced disease management.
• The past decade has seen targeted therapy revolutionize melanoma treatment.

Purpose of the Study:

• To review current surgical options for melanoma.
• To highlight the development pathway of newly approved melanoma agents.
• To discuss emerging treatments on the horizon for melanoma.

Main Methods:

• Literature review of surgical techniques in melanoma.
• Analysis of the development and approval of targeted melanoma therapies since 2011.
• Exploration of ongoing clinical trials for novel melanoma treatments.

Main Results:

• Four new agents (ipilimumab, vemurafenib, dabrafenib, trametinib) approved since 2011 for metastatic melanoma.
• Multiple new agents are in Phase 3 trials, indicating continued progress.
• Integration of surgery with systemic therapies presents a new clinical challenge.

Conclusions:

• Significant progress in melanoma treatment, particularly with targeted therapies.
• Future directions involve optimizing the combination of surgery and novel systemic agents.
• Ongoing research promises further advancements for previously untreatable melanoma.